Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities

Health Policy

Volumn 110, Issue 2-3, 2013, Pages 172-179

  Cleemput, Irina ^a,b   De Laet, Chris ^a  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

Costs and cost analysis; Dialysis; Economics; Health policy; Incentive; Reimbursement

Indexed keywords

ARTICLE; BELGIUM; COST BENEFIT ANALYSIS; DIALYSIS; FACE VALIDITY; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NEPHROLOGIST; NURSE; PERITONEAL DIALYSIS; PROFIT; REIMBURSEMENT;

BELGIUM; COST CONTROL; HEALTH CARE COSTS; HUMANS; PERITONEAL DIALYSIS; REIMBURSEMENT, INCENTIVE; RENAL DIALYSIS;

EID: 84876131397     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.03.001     Document Type: Article

References (20)

1. Just P.M., Riella M.C., Tschosik E.A., Noe L.L., Bhattacharyya S.K., de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008, 86(2-3):163-180.
2. Benain J.P., Faller B., Briat C., Jacquelinet C., Brami M., Aoustin M., et al. Cost of dialysis in France. Nephrologie et Therapeutique 2007, 3(3):96-106.
3. Primer on kidney diseases 2009, National Kidney Foundation, Saunders Elsevier, Philadelphia. 5th edition. A. Greenberg, A. Cheung, T. Coffman, R. Falk, J. Jennette (Eds.).
4. NN. Common report of the GNFB and NBVN [Rapport commun du GNFB et du NBVN pour le college de nephrologie et des centres de traitements de l'insufficiance rénale chronique]; 2008. Available from: http://www.gnfb.be/admin/adminRapportREG.php.
5. NN. The CARI guidelines. Acceptance onto dialysis: mode of dialysis at initiation. CARI (Caring for Autstralians with Renal Impairment). Westmead, Australia. Available from: http://www.cari.org.au/guidelines.php.
6. Haute Authorité de Santé, HAS. Recommandations professionnelles. Indications et non-indications de la dialyse péritonéale chronique chez l'adulte; Octobre 2008.
7. Korevaar J.C., Boeschoten E.W., Dekker F.W., Krediet R.T. What have we learned from NECOSAD? Practical implications for peritoneal dialysis patients. Peritoneal Dialysis International 2007, 27(1):11-15.
8. Murray M.A., Brunier G., Chung J.O., Craig L.A., Mills C., Thomas A., et al. A systematic review of factors influencing decision-making in adults living with chronic kidney disease. Patient Education and Counseling 2009, 76(2):149-158.
9. Cleemput I., Beguin C., de la Kethulle Y., Gerkens S., Jadoul M., Verpooten G., et al. Organisation and financing of chronic dialysis in Belgium. KCE Reports 124C. Health Technology Assessment (HTA) 2010, Belgian Health Care Knowledge Centre (KCE), Brussels.
10. Lee A., Gudex C., Povlsen J.V., Bonnevie B., Nielsen C.P. Patients' views regarding choice of dialysis modality. Nephrology, Dialysis, Transplantation 2008, 23(12):3953-3959.
11. Gerkens S., Farfan M.I., Desomer A., Stordeur S., De Waroux M., Van de Voorde C., et al. The Belgian Health System in 2010. KCE Reports 138C. Health Services Research (HSR) 2010, Belgian Health Care Knowledge Centre (KCE), Brussels.
12. Personal communication.
13. National Institute for Health and Disability Insurance. Dialysevragenlijst; 2006.
14. Dor A., Pauly M.V., Eichleay M.A., Held P.J. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Care Finance and Economics 2007, 7(2-3):73-111.
15. ERA-EDTA Registry ERA-EDTA Registry 2005 annual report 2007, 129. Academic Medical Centre, Department of Medical Informatics, Amsterdam, The Netherlands.
16. Kleophas W., Reichel H. International study of health care organization and financing: development of renal replacement therapy in Germany. International Journal of Health Care Finance and Economics 2007, 7(2-3):185-200.
17. Vanholder R., Davenport A., Hannedouche T., Kooman J., Kribben A., Lameire N., et al. Reimbursement of dialysis: a comparison of seven countries. Journal of the American Society of Nephrology 2012, 23(8):1291-1298.
18. Harris A. The organization and funding of the treatment of end-stage renal disease in Australia. International Journal of Health Care Finance and Economics 2007, 7(2-3):113-132.
19. Manns B.J., Mendelssohn D.C., Taub K.J. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. International Journal of Health Care Finance and Economics 2007, 7(2-3):149-169.
20. Fukuhara S., Yamazaki C., Hayashino Y., Higashi T., Eichleay M.A., Akiba T., et al. The organization and financing of end-stage renal disease treatment in Japan. International Journal of Health Care Finance and Economics 2007, 7(2-3):217-231.